Thesis
NVO is transitioning from a completed Cycle Wave 2 into a new multi-year expansion phase. The long-term bull structure remains intact, with fundamentals now acting as a catalyst for the next cycle leg.
Context
- Weekly timeframe
- Primary bull trend originates from the 2009 GFC low (< $1)
- Cycle Wave 1 completed in July 2024
- Deep corrective Cycle Wave 2 now appears complete
What I see
-Structural reversal underway from long-term trend support
- Price stabilizing in a major accumulation / buy zone
- New Wegovy pill acts as a fundamental trigger aligning with the technical reversal
- Momentum and structure support the start of Cycle Wave 3
What matters now
- Holding the current base keeps the Cycle Wave 3 thesis intact
- This phase is about accumulation, not timing short-term moves
Buy / Accumulation zone
- Current zone remains suitable for long-term positioning
- This is where multi-year risk/reward is defined
Targets
- Cycle Wave 3 (1.618 Fib): ~$273. Expected around early 2029. Approx. +450% from the buy area
- Cycle Wave 5: ~$415. Expected around 2033. Approx. +730% from the buy area
Income
- Dividend yield ~2.1% adds meaningful carry while holding
Conclusion
Strong technical cycle alignment + improving fundamentals make
NVO a compelling long-term hold. This is a position built to be held through volatility, not traded.
Context
- Weekly timeframe
- Primary bull trend originates from the 2009 GFC low (< $1)
- Cycle Wave 1 completed in July 2024
- Deep corrective Cycle Wave 2 now appears complete
What I see
-Structural reversal underway from long-term trend support
- Price stabilizing in a major accumulation / buy zone
- New Wegovy pill acts as a fundamental trigger aligning with the technical reversal
- Momentum and structure support the start of Cycle Wave 3
What matters now
- Holding the current base keeps the Cycle Wave 3 thesis intact
- This phase is about accumulation, not timing short-term moves
Buy / Accumulation zone
- Current zone remains suitable for long-term positioning
- This is where multi-year risk/reward is defined
Targets
- Cycle Wave 3 (1.618 Fib): ~$273. Expected around early 2029. Approx. +450% from the buy area
- Cycle Wave 5: ~$415. Expected around 2033. Approx. +730% from the buy area
Income
- Dividend yield ~2.1% adds meaningful carry while holding
Conclusion
Strong technical cycle alignment + improving fundamentals make
関連の投稿
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
